Fenbendazole and the “Joe Tippens Protocol”: What the Evidence Actually Shows
A business owner credited a veterinary dewormer with curing his terminal lung cancer. The story spread worldwide, and thousands of people began self-dosing. This site reviews the public record — the research, the regulatory warnings, and the documented harms — so patients and caregivers can understand what is actually known.
Bottom line up front: fenbendazole is not approved to treat cancer in humans. No completed clinical trial has shown it works, and regulators have documented real harm from unsupervised use. If you or someone you love has cancer, decisions about treatment belong with your oncology team. We publish no doses, ever — see why.
On this page
- Who is Joe Tippens?
- What the reported regimen included
- What the research actually shows
- Is it safe? What regulators say
- Our position
- Guides for patients and caregivers
Who is Joe Tippens?
In August 2016, Oklahoma businessman Joe Tippens was diagnosed with small cell lung cancer that had spread widely. After standard chemoradiation, his doctors found no detectable disease in early 2017. In a blog he later launched — and in podcasts, YouTube interviews, and viral posts — he credited his recovery to a fenbendazole regimen suggested by a veterinarian friend. His account, published on his own site, mycancerstory.rocks, is the origin of the phrase “Joe Tippens Protocol.”
His story is genuine and moving, and we treat him respectfully. But a single recovery followed by self-reported attribution is an anecdote, not evidence of cause and effect — especially because our documented timeline shows he also received conventional treatment and, by public accounts including a peer-reviewed commentary, participated in an immunotherapy clinical trial. We break down exactly what is documented, and what is not, in The Joe Tippens Story: A Documented Timeline.
What the reported regimen included
According to the public account that made the regimen famous, it combined a veterinary fenbendazole product with several dietary supplements (the account mentions CBD oil, curcumin, and milk thistle). Versions shared on forums differ, and third-party sites have added their own variations, some of which diverge from anything the Tippens account described.
You will notice what is missing from this page: amounts, schedules, and “how to take it” instructions. That is deliberate. Because no controlled human trial has established a safe or effective dose of fenbendazole for cancer, any published human dose is a guess — and published adverse-event reports show that guessing has consequences. You can read about the documented risks in Fenbendazole Safety: Known Side Effects and Reported Adverse Events.
What the research actually shows
The evidence falls into four layers, and they are not interchangeable:
- Laboratory studies. In test tubes and cell cultures, fenbendazole can kill cancer cells. A 2018 study in Scientific Reports found it disrupts microtubules and glucose metabolism in human cancer cells. Many cell-culture findings fail to translate to patients.
- Animal studies. The same research line showed tumor growth slowing in mice fed the drug. Mice are not people, and the doses used were studied under laboratory conditions.
- Case reports. A handful of published case reports and small case series describe cancer patients who self-administered the drug and improved. Case reports cannot separate the drug’s effect from concurrent treatment, natural disease course, or chance.
- Clinical trials. None completed. As of our last review, no controlled trial has tested fenbendazole as a cancer treatment in humans, and the American Society of Clinical Oncology published a clinical notice recommending against its use for cancer.
We explain each layer, with citations, in Fenbendazole and Cancer: What the Evidence Actually Shows. For the related drugs that are being formally studied, see our coverage of benzimidazole trials — and why the absence of trials matters for interpreting the story.
Is it safe? What regulators say
“Safe in dogs” does not mean “safe for people.” Animal-drug approvals are based on animal physiology, animal doses, and animal quality standards. Meanwhile, the FDA’s Center for Veterinary Medicine has reported bone marrow suppression in dogs receiving extra-label (non-approved) fenbendazole use, medical literature documents liver injury signals, and oncologists warn about interactions with chemotherapy. We summarize the documented record in our safety review, and explain the regulatory logic in Why Veterinary Drugs Are Not Cleared for Human Use.
Our position
We do not recommend fenbendazole or any part of this regimen. That is not a claim that the story is false, and it is not a prediction about future research — repurposing old drugs is a legitimate scientific strategy, and we cover it fairly. Our position follows directly from the evidence: no controlled trial has shown benefit in humans, plausible mechanisms exist only in the lab, documented harm reports exist, and proven treatments with known benefit profiles are available. If you are considering any add-on therapy, our guide to evaluating treatment claims includes specific questions to bring your oncologist.
Guides for patients and caregivers
- How to Evaluate a Cancer Treatment Claim Online — a step-by-step method with red flags.
- The Joe Tippens Story: A Documented Timeline — what is verifiable, from diagnosis to viral fame.
- Fenbendazole and Cancer: What the Evidence Actually Shows — the research, layer by layer.
- Fenbendazole Safety: Known Side Effects and Adverse Events — documented harms and warnings.
- Why Veterinary Drugs Are Not Cleared for Human Use — the rules and the risks.
How this site works
Every article cites primary sources — regulators, peer-reviewed journals, clinical trial registries, and the original documents themselves. We update core pages at least twice a year and correct errors transparently. The site is funded by advertising; we sell nothing, use no affiliate links, and accept no sponsored posts. Details in About; data handling in our Privacy Policy.
Found an error? Tell us — corrections are noted publicly on each page.